
L7 bassist, photographer, and multidisciplinary artist Jennifer Finch has been diagnosed with an aggressive form of brain cancer and is currently undergoing treatment, the band confirmed Monday. Finch will not join L7 for the fall 2026 U.S. leg of the band’s farewell “Last Hurrah Tour” — but at her own request, the band is continuing the run as planned, with Tsuzumi Okai stepping in on bass. A GoFundMe campaign has been launched to help cover Finch’s treatment and recovery costs.
STREAM THE METAL BREAKDOWN DAILY NOW:
Scott Penfold gives his honest take on today’s hard rock and metal headlines. Download the free Loaded Radio App on Apple iOS and Google Play to stream it live.
What We Know About Jennifer Finch’s Diagnosis
According to L7, what initially looked like a treatable condition — addressable through a full course of radiation — progressed rapidly. Unforeseen complications required Finch to undergo multiple surgeries, resulting in significant physical limitations. She now requires extensive ongoing medical care, rehabilitation, and professional in-home assistance.
This isn’t the first the public has heard of a health issue. Finch had already missed L7’s summer 2026 tour dates — including stops in Toronto, Montreal, Red Rocks, and a Belgian festival date — after the band announced in early June that she’d be sitting out due to “a recent health concern requiring extended treatment.” At the time, Donita Sparks expressed optimism that Finch would be back by fall, writing on social media, “She’s a tough cookie!” Today’s update makes clear the situation has become considerably more serious in the weeks since.
‘Jennifer Is Family’: L7’s Statement
Sparks addressed the diagnosis directly on behalf of the band: “We are all devastated by the news and are surrounding her with love, protecting her privacy and dignity, while helping raise the resources she urgently needs for the care ahead. Jennifer is family, and we want her to feel the full strength of the community that has loved and supported her for so many years.”
That balance — grief paired with a clear call to action — is why the band’s immediate priority is getting Finch’s GoFundMe in front of as many fans, friends, and members of the wider creative community as possible.
The Tour Will Go On — Because Jennifer Asked For It
L7’s farewell tour was planned with all four members in good health and spirits. With Finch unable to join, the band could have paused the run entirely — instead, they’re proceeding at her explicit request. Tsuzumi Okai, who previously served as a touring bassist for LIMP BIZKIT in 2018, will fill in for the fall dates, continuing in the same role she took on for L7’s summer shows.
The “Last Hurrah Tour” is billed as the first leg of L7’s final world tour, kicking off October 9 in Phoenix and running through mid-November, with stops including Austin, Dallas, Nashville, Atlanta, Washington D.C., New York City, Chicago, and Seattle before wrapping with a hometown celebration in Los Angeles. For a band that’s spent four decades commanding fans “to their feet and their ballot box,” as their own bio puts it, closing out that run in front of their hometown crowd carries extra weight now.
L7’s Legacy — And How To Help
L7 formed in Los Angeles in 1985 and released their self-titled debut in 1988, before breaking through with 1992’s “Bricks Are Heavy,” which peaked at No. 160 on the Billboard 200 and produced the alt-rock staple “Pretend We’re Dead,” a No. 8 hit on the Alternative Airplay chart. Follow-ups “Hungry for Stink” (1994) and “The Beauty Process: Triple Platinum” (1997) reached No. 117 and No. 172 on the Billboard 200, respectively. The band’s songs found a second life on film soundtracks, with “Shitlist” appearing in both “Pet Sematary 2” and “Natural Born Killers,” and “Shove” featured in “Tank Girl.” After going on hiatus in 2001, L7 reunited for a 2015 tour, which led to the 2016 documentary “L7: Pretend We’re Dead,” and released “Scatter the Rats” in 2019 — their first new album in 20 years, via Joan Jett’s Blackheart Records.
Fans looking to support Finch directly can contribute to the GoFundMe campaign launched by her friends, collaborators, and family, linked in L7’s official statement.
TL;DR
- L7 bassist Jennifer Finch has been diagnosed with an aggressive form of brain cancer
- What began as a treatable condition progressed rapidly, requiring multiple surgeries and ongoing in-home care
- Finch will miss the fall 2026 U.S. leg of L7’s farewell “Last Hurrah Tour,” which runs October 9 (Phoenix) through mid-November (Los Angeles)
- At Finch’s own request, L7 is continuing the tour with fill-in bassist Tsuzumi Okai (ex-Limp Bizkit touring member)
- A GoFundMe has been launched to help cover Finch’s treatment and recovery costs
- Finch had already missed L7’s summer 2026 shows for an undisclosed health concern before today’s fuller update
FAQ
What kind of cancer does Jennifer Finch have?
L7 has confirmed Finch is being treated for an aggressive form of brain cancer that progressed rapidly despite an initial course of radiation, requiring multiple surgeries.
Will Jennifer Finch tour with L7’s Last Hurrah Tour?
No. Finch will not join the fall 2026 U.S. leg. She has asked the band to continue without her, and L7 is doing so out of respect for her wishes.
Who is replacing Jennifer Finch on bass for L7’s tour?
Tsuzumi Okai, who previously served as a touring bassist for Limp Bizkit in 2018, is filling in on bass, continuing the role she took during L7’s summer 2026 shows.
How can fans help Jennifer Finch?
Finch’s friends, family, and collaborators have launched a GoFundMe campaign to help cover the costs of her ongoing treatment and recovery.
When does L7’s Last Hurrah Tour start?
The U.S. leg kicks off October 9 in Phoenix and runs through mid-November, wrapping with a hometown show in Los Angeles.
Sending Jennifer Finch and the entire L7 family strength today. If you’re able, consider supporting her GoFundMe. Follow Loaded Radio for daily rock and metal news.
The post L7 Bassist Jennifer Finch Diagnosed With Aggressive Brain Cancer appeared first on Loaded Radio.